[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![internpierre Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1717832611899273216.png) Intern Pierre [@internpierre](/creator/twitter/internpierre) on x 1134 followers
Created: 2025-07-20 08:50:00 UTC

If you’re involved in $HIMS this lawsuit is something to note. It highlights key challenges in the telehealth industry, particularly around regulatory ambiguity. It questions how broadly compounding pharmacies can interpret “personalization” rules when supplying high-demand drugs and underscores the duty of corporate boards to rigorously assess regulatory risks, even when chasing innovative business opportunities.




XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946855097822306809/c:line.svg)

**Related Topics**
[hims](/topic/hims)
[drugs](/topic/drugs)
[telehealth](/topic/telehealth)
[$hims](/topic/$hims)
[hims hers](/topic/hims-hers)
[stocks consumer defensive](/topic/stocks-consumer-defensive)
[$issc](/topic/$issc)

[Post Link](https://x.com/internpierre/status/1946855097822306809)